Formula Center ItaliaRESEARCH · DEVELOPMENT · HUMAN TELEMETRY
ITEN
FORMULA CENTER ITALIA / SINCE 2018

An intuition on track.
A story that continues.

Research, people, patents, resources and experiments: the path that led Formula Center Italia from the first driver tests to the different horizons of human telemetry.

THE IDEA OF DAVIDE VENDITTI

Know the medium.
Listen to the signals.
Understanding the person.

RCST Human Telemetry System, original project trademarkOriginal brand · archive 2019
2018–2019 / THE FIRST PROTOTYPE

RCST.
Human Telemetry System.

Personal telemetry takes shape in motorsport with RCST, the first prototype of the Formula Center Italia route.

The presentation of 18 April 2018 at the San Raffaele Telematic University of Rome introduces a wearable system to observe the driver while driving. The technical shirt, sensors and track tests are the roots from which Humetry technology develops.

Speakers during the presentation of the RCST system in Vallelunga, with the team's logos in the background
Presentation and demonstration of the RCST system in Vallelunga, September 2018. Formula Center Italia archive.
RCST presentation with speakers and technical mannequin at San Raffaele
Presentation of the RCST project, Rome, 2018 · archive
Driver and operators around a single-seater in the pit lane
Track preparation · project motorsport archive
THE PATH / THE PEOPLE

Passion, meetings.
A shared experience.

Two young people in the paddock during an evening
Together in the paddock
Two young people next to a single-seater in the garage
Daily life in the garage
Two people in front of sketches of Lamborghini cars
The world of racing meets design
Two people in front of the Medtronic sign
A meeting in the world of medical technology
Group photo at the RCST presentation in Vallelunga
FCI archive · presentation of the RCST project in Vallelunga
THE ORIGINS / A FAMILY HISTORY

A shared idea.
Support to help it grow.

The intuition was born from Davide and his father Gaetano Venditti, combining experience on the track with the desire to better understand the person driving.

The family accompanies the project from the first steps: decisive support, especially at the beginning, to move from the idea to the research and the first prototypes. Fabio participates in the journey as a tester of the device on the track.

2018 → TODAY

Every step
opens up a possibility.

Formula Center Italia is the company that develops research and industrial property. Humetry is the technology that brings this vision to different application areas.

2018

Formula Center Italia is born

On 26 June the company took shape. The idea was born from Davide Venditti together with his father Gaetano, starting from their experience in motorsport. Family support is essential to transform it into an entrepreneurial path, especially in the initial phase. His brother Fabio shares the sporting path and the development of the project. Fabio also participates as an official tester of the device on the track, contributing to field validation. The first prototype bears the name RCST Human Telemetry System.

2018

Collaborations and first tests

MegaRide, ART and university expertise, including Federico II, accompany the development. The track tests and the experience with the ACI Sport Federal School in Sardinia bring the system into the competitive context.

2018–2019

Members, the first round and regional support

The process involves private partners and a first round of private capital. The Molise Region grants the support provided for by Action 3.1.1 of the POR FESR/FSE 2014–2020.

2019–2020

The Smart&Start Italia path

FCI is admitted to Smart&Start Italia: decision in December 2019 and contract in 2020. The support accompanies the technological development plan.

2020–2021

From motorsport to medical experience

During Covid-19 the system is adapted to the healthcare context. This is followed by the observational study authorized by the Policlinico Tor Vergata and the registration of the first generation HumetryMED in 2021 as a Class I medical device.

2021

The entry of Paolo Scudieri

Paolo Scudieri's personal investment accompanies a new phase of the corporate and technological path.

2022–2024

International patent grants

After the Italian concession in 2020, the patent path reaches the United States, Europe, Japan and China, through their respective national and regional procedures.

2025

New research and development activities

Technological development and work on the human factor continue. HumetryMED is involved in the activities of the OSH-RO@D project in Vallelunga, as part of BRIC INAIL 2022.

2026

Towards dedicated industrial developments

The new MED generation and the HuMedical project open the first dedicated trajectory. In parallel, the industrial sports path and the Safety and Defense applications are being evaluated.

SHAREHOLDERS, INVESTMENT AND PUBLIC SUPPORT

The resources that have
supported the journey.

2018–2019 / PRIVATE CAPITALCapital increase

The first round

The involvement of the first shareholders and the capital increase support the initial research and development.

2018 / MOLISE REGIONPublic grant

Action 3.1.1

Contribution granted under the POR FESR/FSE Molise 2014–2020, in support of the company's program.

2019–2020 / INVITALIAPublic funding support

Smart&Start Italia

Concession admitted under the Smart&Start Italia program.

The amounts have different natures: private capital, contribution granted and concession permitted. The benefits indicated do not represent a certification of full disbursement.

INDUSTRIAL PROPERTY / INTEGRATED TELEMETRY SYSTEM

An Italian origin.
An international journey.

The patented system bears the names of the inventors Davide and Gaetano Venditti.

From the Italian filing of 9 March 2018, the process continues with the 2019 international PCT application and the subsequent concessions in the selected territories.

IT / 2020

Italy

Granted February 11, 2020
102017000132925

US / 2022

United States

Granted March 1, 2022
US 11259731 B2

EP / 2023

Europe

Granted 7 June 2023
EP 3761875

JP / 2023

Japan

Registered 13 November 2023
JP 7384841

CN / 2024

China

Granted September 27, 2024
CN 112153941 B

The PCT is the international application route; concessions are issued by individual national or regional offices.

SKILLS THAT MEET

The path is being built
with people.

Motorsport & research

MegaRide, ART, University of Naples Federico II and the experience with the ACI Sport Federal School contributed to the initial path.

Clinical experience

The Policlinico Tor Vergata, with the study coordinated by Prof. Massimo Andreoni, is a stage in the transition to medical experimentation.

Safety & sports

The research in OSH-RO@D and the dialogue with the sporting world, including CONI, open new questions on the human factor.

The references describe experiences and interlocutions in the respective periods; they do not constitute a list of current business partnerships.

PARTNERS AND COLLABORATIONS ALONG THE WAY

Skills that
advance research.

2018–2025 / APPLIED RESEARCH

MegaRide

Telemetry research and analysis, starting from motorsport tests.

2025–2026 / NEW GENERATION

DAOS Group

Electronic design and firmware development for the new generation of the device.

2020–2021 / HISTORICAL PATH

ART

Hardware and software in early system configurations and medical experience.

2018 / RCST PROJECT

University of Naples Federico II

Vehicle and automatic engineering skills in the original path.

2018 / RCST PROJECT

Università del Piemonte Orientale

Prof. Giorgio Calabrese's contribution on the issues of driver nutrition.

2018 / RCST PROJECT TEAM

San Raffaele University of Rome

In the team of the RCST project, presented at the Roman university on 18 April 2018.

2018 / RCST PROJECT TEAM

Imperiale Racing

The motorsport team in the RCST project team documented in 2018.

2018 / RCST PROJECT TEAM

Centro Ricerca Racing

Research center present in the original team of the RCST project.

2018 / MOTORSPORT EXPERIMENTATION

ACI

Tests with the young drivers of the ACI Sport Federal School in Sardinia.

2020–2021 / CLINICAL TRIAL

Policlinico Tor Vergata

HumetryMED observational study in the context of the Covid-19 emergency.

BRIC 2022 / ACTIVITIES 2025

INAIL

The OSH-RO@D research program: human factors, health and safety in driving.

From technological development to experimentation: each organization is presented in its own role and period. Support programs and resources are described in the history of the company.

FROM RESEARCH TO THE MARKET

One technological foundation.
Dedicated development paths.

The next phase takes shape
around the needs of each sector.

FORMULA CENTER ITALIA / SINCE 2018

Formula Center Italia

Research, industrial property, experimentation and functional prototypes.
Humetry is the technology and platform through which we develop this heritage.

FIRST DEDICATED DEVELOPMENT PATH

HuMedical

Startup being established to develop and industrialize the new medical generation, complete the regulatory process and reach the market.

The new MED phase
INITIATIVE UNDER EVALUATION

Sports venture

A possible corporate development with players in the sector: from the prototype for drivers to industrialization and subsequent sporting applications.

The sports development path
RESEARCH & COLLABORATIONS

Safety & Defence

Two distinct areas, to be developed with industrial partners and specialists, starting from their respective operational contexts.

Research and applications
THE POINT REACHED

Functional prototypes.
Next industrial phases.

Formula Center Italia has developed functional prototypes in motorsport and medical, developing a wealth of research, experimentation and industrial property.

Transforming this heritage into commercial products and services requires dedicated activities: development, industrialization, validation, compliance and market organization.

This is the phase that the project faces today, starting with the medical path.

LET'S CONNECT IDEAS

An open story
ready for the next collaboration.

Skills, industrial vision and research: let's discuss the next developments.

Talk to the team